Wise to Use Pharmacy Walk-in Clinics?
CBS News | August 2, 2008
The CBS "Early Show" examined the benefits of using retail clinics, citing data from Deloitte's 2008 Survey of Health Care Consumers and recently released Retail Clinics: Facts, Trends, and Implications.
Actionable Information Draws Consumers
Managed Healthcare Executive | August 1, 2008
Opportunities for Health Plans in a Consumer-Driven Market, a report based on Deloitte's 2008 Survey of Health Care Consumers, uncovers consumers’ desire to have personalized and useful information specific to their health problem. The article discusses the findings of the report and quotes Dr. Paul Keckley.
Filling the Health Care IT Gap
AHIP Coverage | July/August 2008
According to Deloitte’s 2008 Survey of Health Care Consumers, Americans want greater control over their medical decisions. This topic and more are discussed in this article from America’s Health Insurance Plans' (AHIP's) magazine.
Bristol Seeks Rest of ImClone
Wall Street Journal | July 31, 2008
Terry Hisey is quoted in this Wall Street Journal article that discusses Bristol-Myers Squibb's offer for ImClone Systems Inc. This move reflects the pharmaceutical industry's growing reorientation toward biotechnology. (subscription required)
Americans Looking Near, Far to Save on Health Care
Associated Press | July 29, 2008
Consumers increasingly are trying alternatives to their local hospitals and doctors, from going abroad for less-costly surgery to seeking quick, basic care at new clinics in drugstores and discounters, says this article. Two Center for Health Solutions reports – one on retail clinics and one on medical tourism – are referenced in the article.
Connect the Dots
Pharmaceutical Executive | July 2008
Joe Slota and Matthew Humphreys, both of Deloitte Consulting LLP, are featured in the July issue of Pharmaceutical Executive in an article discussing the importance of a secure value chain.
Data Management Critical to Meet Member Expectations
Managed Healthcare Executive | July 1, 2008
Consumers want their physicians to provide online access to medical records and test results. And one-fourth are willing to pay extra for it. Deloitte's 2008 Survey of Health Care Consumers and John Bigalke, national managing partner, Life Sciences & Health Care, Deloitte & Touche LLP, are prominently featured in this article.
Market Spotlight: Clinical Research Organizations
Associated Press | May 21, 2008
Terri Cooper is quoted in an Associated Press article regarding outsourcing by big pharma and biotech companies. The outsourcing trend is expected to continue as drug developers farm out more of their needs to cut costs. Read more about this trend in the new Deloitte report, The Changing Face of R&D in the Future Pharmaceutical Landscape.
Quagmire to Goldmine?
The Economist | May 15, 2008
The rapid growth in developing countries prompts a rethink by drug companies. Deloitte's Terry Hisey discusses the issue; article includes data from a recently released point of view, The Right Spice: Pharmaceutical market entry in India.
Deloitte sees 'Fundamental Shift' in Drug Development Strategies
FierceBiotech | May 13, 2008
Big Pharma’s failure to develop enough new blockbuster drugs is combining with other forces to drive fundamental changes in pharmaceutical research and development. Chief among these will be the emergence of “NewPharmaCos” concentrating on genotyped market segments. The companies may be startups or spinoffs of existing pharma companies, Deloitte says in a new report, The Changing Face of R&D in the Future Pharmaceutical Landscape.
Even the Insured Feel Strain of Health Costs
The New York Times | May 4, 2008
Many of the 159 million people covered by employer health insurance are struggling to meet medical expenses that are much higher than they used to be. The Deloitte 2008 Survey of Health Care Consumers is referenced.
Drug Makers' Profit Views Make Tax Credit Assumptions
Wall Street Journal | May 2, 2008
Tom Hogan discusses R&D tax credits among drug makers.
NFPs Should Begin Prepping for New Tax Form
Healthcare Finance News | May 2008
Learn more about filling out the revamped Form 990 next year and the changes that come in handling these new tax form requirements. Jim Sowar discusses the updated Form 990 and how it effects hospital executives.
Cross-Border Small-Scale Buys to Continue in CRO Industry as More Trials Increase in Size and Go Offshore
Analysis Financial Times | April 17, 2008
Terry Hisey is quoted in this Financial Times article in which multiple industry sources discuss the continued amount of cross-border small-scale acquisitions in the contract research organization (CRO) industry.
Treating Technology That Fails to Thrive, Part II
Hospitals & Health Network's Most Wired | April 2008
Part II in a two-part series. Kate Fitzpatrick and James R. Bush provide a guide for post-implementation improvement. The authors discuss a road map for post-implementation improvement and a system improvement approach in this article in Hospitals & Health Network’s Most Wired.
Treating Technology that Fails to Thrive, Part I
Hospitals & Health Network's Most Wired | April 2008
Part I in a two part series. Kate Fitzpatrick and James R. Bush discuss post-implementation improvement of clinical information technology. The authors describe common problems in systems and system implementations in this article in Hospitals & Health Network’s Most Wired.
Moving Beyond e-Pedigree to Value Creation
Pharmaceutical Commerce | March 31, 2008
Joe Slota discusses how pharmaceutical industry-leading manufacturers will soon turn a secure supply chain into a competitive advantage. He explains how pharmaceutical companies need to move beyond mere e-pedigree compliance (defensive strategy) and adopt a holistic, value-based approach (offensive strategy) to achieving a secure value chain and maintaining product integrity.
Genetics May Bring New Life to Failed Drugs
Wall Street Journal | March 24, 2008
As pharmaceutical makers find it increasingly difficult to bring new drugs to market, they are turning to genetic tools to seek uses for medicines that failed to make it out of the development pipeline. Terry Hisey is quoted in this article about the discovery of new links between genes and diseases in the design of new treatments.
Medical Consulting Services Finally Gaining Traction with Employers
Financial Week | March 10, 2008
Medical consulting companies that advise employees are gaining popularity among benefit managers for their ability to empower employees to take control over health care decisions while avoiding costly, unnecessary or inadequate treatment. John Bigalke is quoted in this Financial Week article.
Returns on Medical Consulting Services Worth Cost: Employers
Business Insurance | March 10, 2008
John Bigalke is quoted in this article about programs that are helping employees make informed health care decisions and avoid unnecessary treatments.
‘Medical Home’ Shifts Emphasis to Patient-Centered Care
Business Insurance | March 10, 2008
Paul Keckley is quoted in this article about a new approach in health care that taps coordinated, comprehensive service delivery. Read the article to learn more about the medical home.
Health Care: The Bleeding Edge
Economist | February 28, 2008
The Economist interviews John Bigalke and Paul Keckley live from HIMSS regarding the medical device industry. In this article they discuss the future of the medical home as a near-term possibility within the next five years.
Survey: Consumers Want I.T. Services
Health Data Management | February 28, 2008
The recently released 2008 Survey of Health Care Consumers is featured in this article on the Health Data Management Web site.
Survey: U.S. Consumers Want Changes in Health Care Design, Delivery
Insurance Networking News | February 25, 2008
The 2008 Survey of Health Care Consumers is featured in this Insurance Networking News article. The article quotes both Paul Keckley and Bill Copeland.
Many U.S. Consumers Want Major Changes in Health Care Design, Delivery, Says Survey
HFMA | February 21, 2008
An overview of the 2008 Survey of Health Care Consumers was featured on the HFMA Web site.
Convergence in the Life Sciences Industry Pharmaceutical Processing | January 2008
Terry Hisey and
John Rhodes address the issue of convergence and effective partnering in this article. They explore the perils of partnering and the emergence of alliance networks in the industry.
Market Trends Prompt Need for a Better Operating Model
MD&DI (Medical Device & Diagnostic Industry) | January 2008
Why should medical device companies be concerned about their future? This article explores four significant market trends that will dramatically affect the future of medical device companies.
RFID Moves Beyond Assets
Health Data Management | January 1, 2008
Learn how radio frequency identification technology (RFID) can track clinicians to enable them to better communicate with one another, along with other ideas for how RFID could help improve workflow and patient care. Patrick Rossignol, principal of Deloitte Consulting LLP, discussed various uses for the technology.
Smoother Sailing in the Distribution Channel
Future Pharmaceuticals | Q4 2007
Learn how activity-based fee-for-service (FFS) agreements can benefit life sciences manufacturers and distributors. This featured article discusses FFS models and includes three case studies.
Getting Paid What You Deserve
Health Data Management | December 1, 2007
Some group practices are finding that with a little extra effort, and the help of specialized software, they can get paid a lot more by insurers. Beth Hoffmann, Deloitte Consulting LLP, provides insight into how organizations implementing contract management software should not try to do everything at once but instead start with one major payer.
"Convergence" in Health
Reuters | November 12, 2007
Terry Hisey, principal of Deloitte Consulting LLP and the head of our Life Sciences practice, says the convergence of drugs and medical devices is creating a new level of collaboration between companies and is having a transformational impact on the industry. Watch the video.
Beyond the Pill
The Economist | October 25, 2007
Read the article to see how pharmaceutical firms are casting about for new business models. Terry Hisey, Deloitte Consulting LLP, argues in a new report that such deals go beyond hedging risks in traditional businesses: He reckons they herald a dramatic new “convergence of drugs, devices and diagnostics” that could lead to innovation and new opportunities for growth.
Plan Activates Increased Coverage on Demand
Managed Healthcare Executive | October 1, 2007
Read the article on how marketing and distribution of health insurance products continue to evolve, as does the movement toward creating flexible, innovative products to attract new members. John Bigalke, vice chairman, U.S. health sciences & government leader, Deloitte & Touche LLP, talks about how on-demand coverage upgrades provide consumers with the peace of mind to make decisions about the level of healthcare they want to receive at a known premium, without worrying about how they might protect themselves against a future catastrophic event or serious illness.
Managing Supply Chain’s Last Straw: S-Risk
Future Pharmaceuticals | September 2007
Joe Slota, principal, Deloitte Consulting LLP, provides specific recommendations on developing a proactive and integrated approach to preventing disruptions to your supply chain.
Time for a Second Look at SOX Compliance
HFM Magazine | August 2007
Effectively prepare your tax-exempt health care organization for the Sarbanes-Oxley process by arming yourself with the proper strategic approach, outlined by John Bigalke, national industry leader, Health Sciences & Government Industry Group, Deloitte & Touche LLP, and Steve Burrill, National AERS (Audit and Enterprise Risk Services) Industry leader, Deloitte & Touche LLP.
A Turnaround Tale
Healthcare Financial Management | July 2007
Marvin O’Quinn, chief executive officer of Jackson Health System (JHS), and Kimberly Comer Mulqueen, principal, Deloitte Consulting LLP, describe the novel approach that turned JHS into a profitable health care provider.
Automating Health Plan Enrollment
Health Management Technology | July 2007
Blue Cross and Blue Shield of North Carolina, with the assistance of Brian Keane, principal, and Sahal Laher, senior manager, of Deloitte Consulting LLP, developed Buy Online to reduce service time and satisfy customers.
R&D Commercialization: The Role of Innovation
R&D Directions | May 2007
Jacques Mulder, principal, Deloitte Consulting LLP, describes a five-step approach for life sciences companies to utilize. His approach provides a framework to assist companies in evaluating their existing portfolios and determining adjustments to their commercialization and product mix to meet new and changing market demands.
For additional information, visit our Health Plans, Health Care Providers, Life Sciences and Center for Health Solutions sections.
As used in this document, "Deloitte" means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
